Comments by "Data-JY" (@DataJYdocs) on "Russia starts production of COVID-19 vaccine in Moscow lab | AFP" video.

  1. (proofs) - Today, many Western media and politicians question the speed of the COVID-19 vaccine creation in Russia, raising doubts about its efficacy and authenticity. The secret behind this speed is Russia’s expertise in vaccine research. Since the 1980s, the Gamaleya Center has led the effort to develop a technological platform using adenoviruses, found in human adenoids and normally transmitting the common cold, as "vectors" or vehicles, which can induce a genetic material from another virus into a cell. The gene from adenovirus, which causes the infection, is removed while a gene with the code of a protein from another virus is inserted. This inserted element is small, not a dangerous part of a virus and is safe for the body but still helps the immune system to react and produce antibodies, which protect us from the infection. The technological platform of adenovirus-based vectors makes it easier and faster to create new vaccines through modifying the initial carrier vector with genetic material from new emerging viruses. Such vaccines provoke a strong response from a human body in order to build immunity while the overall process of vector modification and pilot-scale manufacturing takes only a few months. [Excerpts from ( sputnikvaccine.com )].
    1